Pharmac update: Widened access to eligibility criteria for Covid antiviral medicines
From 1 September 2025 the eligibility criteria widened for access to COVID-19 antivirals. The new addition to the eligibility criteria allows access for people who are 50 years and over and considered by their healthcare professional to be at high risk of severe outcomes from COVID-19 infection. Other access criteria remain the same.
Read more